Churn is what blew me away. Very impressive and shows the scalability as well as how invaluable the tool is.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025